Korro Bio
KRRO
52 hedge funds and large institutions have $213M invested in Korro Bio in 2019 Q4 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.81% more ownership
Funds ownership: 0% → 0.81% (+0.81%)
Top Buyers
| 1 |
PA
Perceptive Advisors
New York
|
+$47.2M |
| 2 |
DM
Deerfield Management
New York
|
+$22.1M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$21.4M |
| 4 |
RI
RTW Investments
New York
|
+$20.3M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$19.2M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KFS
51
Kelly Financial Services
Braintree,
Massachusetts
| $1.23K | +$778 | +1 | New |
|
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$778 | +1 | New |
|
KRRO Hedge Fund Activity: Q4 2019 in Review
52 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q4 2019, worth a combined $213M.
Buyers outnumbered sellers: 52 funds opened new KRRO positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $47.2M.
- 52 institutional investors held Korro Bio (KRRO) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $213M of Korro Bio stock for Q4 2019.
- 52 funds opened new Korro Bio positions in Q4 2019 and 0 closed out, a net change of +52 holders.
- The largest Korro Bio buyer in Q4 2019 was Perceptive Advisors, an estimated $47.2M added.
Based on aggregated 13F filings for Q4 2019.